Drug Information

General Information
Drug ID
DR00384
Drug Name
Risperidone
Synonyms
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one; 3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; Belivon; Consta, Risperdal; KS-1106; R 62 766; R 64 766, Risperdal, Risperidone; R 64,766; R 64766; R-118; R-64,766; R-64-766; R-64766; R64,766; R64766; Risperdal; Risperdal (TN); Risperdal Consta; Risperdal M-Tab; Risperdone; Risperidal; Risperidal M-Tab; Risperidona; Risperidona [Spanish]; Risperidone (JAN/USAN/INN); Risperidone (RIS); Risperidone [USAN:BAN:INN]; Risperidone, placebo; Risperidonum; Risperidonum [Latin]; Risperin; Rispolept; Rispolin; Sequinan
Drug Type
Small molecular drug
Indication Schizophrenia [ICD11: 6A20] Approved [1]
Therapeutic Class
Antipsychotic Agents
Structure
3D MOL 2D MOL
Formula
C23H27FN4O2
Canonical SMILES
CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
InChI
InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3
InChIKey
RAPZEAPATHNIPO-UHFFFAOYSA-N
CAS Number
CAS 106266-06-2
Pharmaceutical Properties Molecular Weight 410.5 Topological Polar Surface Area 61.9
Heavy Atom Count 30 Rotatable Bond Count 4
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 6
XLogP
2.7
PubChem CID
5073
PubChem SID
103170825 , 103856459 , 103914673 , 103916252 , 11111724 , 11111725 , 11467057 , 11468177 , 11486814 , 11528727 , 12013967 , 14904216 , 17405630 , 25819945 , 26719830 , 26753640 , 29224142 , 46386613 , 46505850 , 49658633 , 49666400 , 49681677 , 49699257 , 49830253 , 50106974 , 50106975 , 50123965 , 53778180 , 53790689 , 57322595 , 631811 , 7379882 , 7847492 , 7980523 , 80652519 , 81092846 , 8153122 , 85089206 , 85170980 , 85209258 , 85231208 , 85788353 , 89736125 , 92126063 , 92303273 , 92308377 , 92308738 , 92712792 , 93166420 , 93617025
ChEBI ID
ChEBI:8871
TTD Drug ID
D01AZG
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
Drug-Transporter Activity Data
Drug-Transporter Activity Data P-GP Transporter Info Km = 12.4 microM Baculovirus-infected insect cells-MDR1 [3]
References
1 Risperidone was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition. Clin Pharmacol Ther. 2005 Jul;78(1):43-51.
3 In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sci. 2002 May 31;71(2):163-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.